Last reviewed · How we verify

NCT02993965

State Immunization Information Systems to Improve HPV Vaccination Rates

Completed NA Last updated 20 August 2020
What this trial tests

NA trial testing Vaccine Reminder/Recall in Vaccine in 77,716 participants. Completed in 31 July 2020.

Timeline
21 February 2017
Primary endpoint
15 March 2019
31 July 2020

Quick facts

Lead sponsorUniversity of Colorado, Denver
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment77,716
Start date21 February 2017
Primary completion15 March 2019
Estimated completion31 July 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 11 to 17, any sex, with Vaccine or Human Papiloma Virus Vaccine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (with a more focused look at the new two dose series for 11-14 year olds).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Centralized Reminder/Recall for Human Papillomavirus Vaccination: Findings From Two States-A Randomized Clinical Trial.
    Gurfinkel D, Kempe A, Albertin C, Breck A, et al · · 2021 · cited 15× · PMID 33846054 · DOI 10.1016/j.jadohealth.2021.02.023

Verify or expand the search:

Other recruiting trials for Vaccine

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02993965.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing